Injectable-route preclinical evidence Injectable-route evidence is substantially more developed: IP (intraperitoneal): most extensively studied
Cycle length Typical protocols run 4-8 weeks
SCFAs, in particular butyrate, serve as energy sources for colonocytes and regulate intestinal homeostasis, metabolism, and immune responses (Salvi and Cowles, 2021
Limited to superficial pigmentation 2
Key Benefits: Smooths the look of stubborn deep lines, wrinkles & creases Targets visible expression lines, including marionette, lip, frown & nasolabial folds (smile lines) Helps wrinkle depth appear shallower over time Featured Ingredients: Neuropeptides: Protein-like messenger molecules reduce the look of stubborn expression lines and deep creases by supporting visible skin renewal for a relaxed, smooth appearance